Gaining Small Caps: Matrix Service Company (NASDAQ:MTRX), Internap Corporation (NASDAQ:INAP), Alamos Gold (NYSE:AGI), Viavi Solutions (NASDAQ:VIAV), Trevena (NASDAQ:TRVN)

Matrix Service Company (NASDAQ:MTRX) shares advanced 7.45% in last trading session and ended the day at $21.49. MTRX Gross Margin is 6.30% and its has a return on assets of 2.40%. Matrix Service Company (NASDAQ:MTRX) quarterly performance is 18.86%.

Matrix Service Company is engaged in providing engineering, fabrication, infrastructure, construction, and maintenance services primarily to the oil, gas, power, petrochemical, industrial, mining and minerals markets.

Matrix Service Company (NASDAQ:MTRX) reported Revenue for the fourth quarter ended June 30, 2015 was $370.5 million compared to $344.4 million in the same period a year earlier, an increase of $26.1 million, or 7.6%. In fiscal 2015, the Company generated net income of $10.9 million, or $0.40 per fully diluted share. In the same period a year earlier, the Company earned $7.6 million, or $0.28 per fully diluted share.

Internap Corporation (NASDAQ:INAP) ended the last trading day at $8.98. Company weekly volatility is calculated as 5.67% and price to cash ratio as 30.40. Internap Corporation (NASDAQ:INAP) showed a weekly performance of 19.89%.

Internap is the high-performance Internet infrastructure provider thatpowers the applications shaping the way we live, work and play. Our hybridinfrastructuredelivers performance without compromise blending virtual and bare-metal cloud, hosting and colocation services across a global network of data centers, optimized from the application to the end user and backed by rock-solid customer supportand a 100% uptime guarantee.

Internap Corporation (NASDAQ: INAP), announced that the Company is exploring strategic alternatives to maximize shareholder value. The Board of Directors created a Strategy Committee of independent directors early this year. Morgan Stanley & Co. LLC and Greenberg Traurig, LLP have been advising the committee on strategic and legal matters.

On 01 September, Alamos Gold, Inc. (NYSE:AGI) shares advanced 7.32% and was closed at $4.40. AGI EPS growth in last 5 year was -34.46%. Alamos Gold, Inc. (NYSE:AGI) year to date (YTD) performance is -38.29%.

Alamos is a Canadian-based intermediate gold producer with diversified production from three operating mines in North America. This includes the Young-Davidson mine in northern Ontario, Canada and the Mulatos and El Chanate mines in Sonora State, Mexico.

Alamos Gold Inc. (NYSE:AGI) announced the purchase of 8,000,000 common shares (the “Shares”) of AuRico Metals Inc. (“AuRico”), representing approximately 6.34% of the outstanding common shares of AuRico (the “Transaction”). The Shares are being acquired by Alamos by way of private placement at a price of C$0.70 per Share.

Viavi Solutions Inc. (NASDAQ:VIAV) shares advanced 5.40% in last trading session and ended the day at $5.66. VIAV Gross Margin is 45.60% and its has a return on assets of -3.90%. Viavi Solutions Inc. (NASDAQ:VIAV) quarterly performance is -23.87%.

Viavi Solutions software and hardware platforms and instruments deliver end-to-end visibility across physical, virtual and hybrid networks. Precise intelligence and actionable insight from across the network ecosystem optimizes the service experience for increased customer loyalty, greater profitability and quicker transitions to next-generation technologies.

On 27 August, Viavi Solutions Inc. (NASDAQ:VIAV) announced it is expanding its portfolio of software-defined network test and monitoring solutions with the new GigaStor Software Edition to manage performance and user experience in virtual and cloud environments. The new software configurations, which Viavi is demonstrating at VMworld, allow network and server teams to capture and save 250 GB or 1 TB of continuous traffic to disk for in-depth performance and forensic analysis.

Trevena, Inc. (NASDAQ:TRVN) caters to the Healthcare space. Its weekly performance is 62.32%. On the last day of trading company shares ended up $9.09. Trevena, Inc. (NASDAQ:TRVN) distance from 50-day simple moving average (SMA50) is 44.79%.

Trevena, Inc. is a clinical stage biopharmaceutical company that discovers, develops and intends to commercialize therapeutics that use a novel approach to target G protein coupled receptors, or GPCRs. Using its proprietary product platform, Trevena is developing four biased ligand product candidates it has identified – TRV027 to treat acute heart failure.

Trevena Inc. (NASDAQ:TRVN) announced after the close Monday that its Phase 2b trial of TRV130 in moderate to severe acute postoperative pain after abdominoplasty surgery met its primary endpoint.